PT Royal Prima Tbk (IDX:PRIM)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
87.00
+4.00 (4.82%)
Jun 19, 2026, 4:02 PM WIB
Market Cap293.91B +47.5%
Revenue (ttm)329.89B +5.4%
Net Income-19.56B
EPS-5.76
Shares Out 3.38B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,308,700
Open83.00
Previous Close83.00
Day's Range82.00 - 87.00
52-Week Range55.00 - 116.00
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateJul 31, 2026

About PT Royal Prima Tbk

PT Royal Prima Tbk engages in providing hospital services and drugs in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. The company also provides health services, such as inpatient and outpatient medical services, including specialist and sub-specialist care. In addition, the company offers orthopaedic, eye, neurology, internal medicine, obstetrics and gynaecology, heart, lung, Ent-kl, urology. Further, it provides other services, including general surgery, surgical... [Read more]

Sector Healthcare
Founded 2013
Employees 797
Stock Exchange Indonesia Stock Exchange
Ticker Symbol PRIM
Full Company Profile

Financial Performance

In 2025, PT Royal Prima Tbk's revenue was 338.91 billion, an increase of 13.21% compared to the previous year's 299.36 billion. Losses were -21.82 billion, 18.5% more than in 2024.

Financial Statements